Pharma

Pharma articles feature opinion and analysis of Big Pharma including impacts on economics, public policy, social life, and more.

Pharma articles at Brownstone Institute are translated into multiple languages.

  • All
  • Censorship
  • Economics
  • Education
  • Government
  • History
  • Law
  • Masks
  • Media
  • Pharma
  • Philosophy
  • Policy
  • Psychology
  • Public Health
  • Society
  • Technology
  • Vaccines
FDA “GRAS” Additives and Artificial Food Coloring Banned in Many Countries Still “Certified” in the USA

FDA “GRAS” Additives and Artificial Food Coloring Banned in Many Countries Still “Certified” in the USA

SHARE | PRINT | EMAIL

GRAS food additives and food colorings will be one of many things that Trump-appointed HHS Director Robert F. Kennedy, Jr. and his new FDA commissioner will need to address, alongside an extended list of overdue, critical FDA modernizations and reforms.

FDA “GRAS” Additives and Artificial Food Coloring Banned in Many Countries Still “Certified” in the USA Read More

Empowered by the State, Condemned by the Crisis: The Purdue Paradox

Empowered by the State, Condemned by the Crisis: The Purdue Paradox

SHARE | PRINT | EMAIL

Just as taxpayer-funded research paved the way for the Covid-19 pandemic through gain-of-function experiments in Wuhan, the government’s blind spot—or complicity—in fostering addiction treatment models fueled by profit underscores its failure to protect its citizens.

Empowered by the State, Condemned by the Crisis: The Purdue Paradox Read More

The Vaccine Paradox

The Vaccine Paradox

SHARE | PRINT | EMAIL

It’s an interesting paradox…Big Pharma’s power has managed to paint its critics as lunatics. After all, in the public’s mind, “anti-vaxxer” and “flat-earther” are essentially the same type of person. The problem only arises when people Google our names.

The Vaccine Paradox Read More

FDA Knows That China and India Drug Quality Is Poor, But Independently Collects and Tests Only about 0.001%

FDA Knows That China and India Drug Quality Is Poor, But Independently Collects and Tests Only about 0.001%

SHARE | PRINT | EMAIL

Trusting for-profit, overseas manufacturers to police themselves on quality control via self-selected “mailed-in” sampling doesn’t work. Patients filling prescriptions hoping to treat a critical medical condition could instead be adversely affected with impure products stealthily making them even sicker.

FDA Knows That China and India Drug Quality Is Poor, But Independently Collects and Tests Only about 0.001% Read More

Stay Informed with Brownstone Institute